Regulations.gov document
ICH Harmonised Tripartite Guidelines "Impurities in New Drug Products Q3B(R2)"…
Supporting & Related Material · FDA-2006-P-0025 · posted Jul 11, 2009
Key facts
| Document ID | FDA-2006-P-0025-0018 |
|---|---|
| Title | ICH Harmonised Tripartite Guidelines "Impurities in New Drug Products Q3B(R2)" - [Sanofi-aventis U.S., LLC (sanofi-aventis) - Petition Supplement(2)] |
| Document type | Supporting & Related Material |
| Subtype | SUP-Supplement (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2006-P-0025 |
| Posted | Jul 11, 2009 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: